High-fat Yogurt and Plasma Lipids Profile

Sponsor
Shahid Beheshti University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05589350
Collaborator
(none)
30
1
2
4
7.4

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the effect of saturated fat intake from different source on cardiometabolic risk markers in healthy subjects. The main question it aims to answer are:

-Does intake of saturated fat in the form of high-fat yogurt have a different effect on cardiometabolic risk factors than intake of the same amount from butter? In this study, in two periods of 4 weeks, the effect of receiving saturated fat from high-fat yogurt compared to receiving the same amount of saturated fat from butter and low-fat yogurt on the plasma concentration of lipids, cholesterol, insulin, and some inflammatory factors will be studied in healthy subjects.

Condition or Disease Intervention/Treatment Phase
  • Other: saturated fat intake
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comparison of the Impact of Saturated Fat From High-fat Yogurt or Low-fat Yogurt and Butter on Cardiometabolic Risk Markers: a Randomized Cross-over Trial
Actual Study Start Date :
Oct 15, 2022
Anticipated Primary Completion Date :
Feb 15, 2023
Anticipated Study Completion Date :
Feb 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: High-fat yogurt

Daily consumption of 1-2 servings (based on daily calorie requirement) of high-fat yogurt

Other: saturated fat intake
Intake of saturated fat from yogurt and animal butter daily for 4-week period

Active Comparator: Low-fat yogurt and butter

Daily consumption of 1-2 servings of low-fat yogurt along with daily consumption of about 10 grams of animal butter

Other: saturated fat intake
Intake of saturated fat from yogurt and animal butter daily for 4-week period

Outcome Measures

Primary Outcome Measures

  1. Plasma lipid profile [4 weeks]

    Plasma concentrations of cholesterol, high-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, and triglyceride

Secondary Outcome Measures

  1. Glycemic measures [4 weeks]

    Fasting plasma concentrations of glucose and insulin

Other Outcome Measures

  1. Inflammatory markers [4 weeks]

    Plasma concentrations of c-reactive protein and interleukin 6

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy people who do not use lipid-lowering, blood pressure control or diabetes medications
Exclusion Criteria:
  • Taking supplements of omega-3 fatty acids, or antioxidants

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Nutrition Research Unit, National Nutrition and Food Technology Research Institute Tehran Iran, Islamic Republic of 19395-4741

Sponsors and Collaborators

  • Shahid Beheshti University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Javad Nasrollahzadeh, Associate Professor, Shahid Beheshti University
ClinicalTrials.gov Identifier:
NCT05589350
Other Study ID Numbers:
  • 32333
First Posted:
Oct 21, 2022
Last Update Posted:
Jan 5, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 5, 2023